Form 4 for JBIO Jade Biosciences, Inc.
Accepted 2024-04-12 00:00:00 ET · period of report 2024-04-10 · accession 0001415889-24-010773 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-04-12 | 2024-04-10 | JBIO | Eldridge George A | SEE REMARKS | S - Sale+OE | $26.85 | -7,500 | 2,731 | -73% | -$201.4K |
| D | 2024-04-12 | 2024-04-10 | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $2.14 | +7,500 | 9,460 | +383% | +$16.1K |
| D | 2024-04-12 | 2024-04-10 | JBIO | Eldridge George A | SEE REMARKS | M - OptEx | $0.00 | -7,500 | 43.8K | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-10 | S | D | 771 | $27.56 | 1,960 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.35 to $27.74, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2024-04-10 | S | D | 6,729 | $26.77 | 2,731 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.32 to $27.315, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2024-04-10 | M | A | 7,500 | $2.14 | 9,460 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2024-04-10 | M | D | 7,500 | $0.00 | 43,763 | D | $2.14 · — to 2031-04-01 | 7,500 Common Stock | (F4) A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter. |